Post

New research · Ophthalmology
PloS one · 4d
AI / informaticsPloS one · 2026

Artificial intelligence for early detection of diabetic retinopathy: A vision transformer-based approach.

Asma ElAdel, Imen Filali, Mourad Zaied
Read paper
OphthalmologyAI / informatics

Vision transformer artificial intelligence model detects diabetic retinopathy with high accuracy

Artificial intelligence for early detection of diabetic retinopathy: A vision transformer-based approach.

Asma ElAdel … Mourad Zaied
PloS one · 2026
Background

Early identification of diabetic retinopathy (diabetic retinopathy), which is a primary cause of vision impairment globally, is a crucial phasis for effective intervention and treatment.

Methods

This paper proposes a Vision Transformer (Vision Transformer)-based model, specifically using a Compact Convolutional Transformer (Compact Convolutional Transformer), for early automated detection of diabetic retinopathy.

97%
Results
97%
correctly identified diabetic eye disease in nearly all cases checked
“
Conclusion

These results highlight the potential of transformer-based designs in medical picture analysis, as well as the implications for telemedicine and e-health solutions in real-time, especially in cases of low-resource settings.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving